rVSV-ZEBOV vaccine first real-world data support prophylactic use for future Ebola outbreaks:…
Real-world data show rVSV-ZEBOV vaccine is 84 per cent effective against Ebola, supporting its use in future outbreaks
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
rVSV-ZEBOV vaccine
Merck and Gavi sign purchase commitment for Ebola vaccine
Agreement will help prepare for future outbreaks and push vaccine towards regulatory approval